Cogent Biosciences, Inc.
Cogent Biosciences, Inc.（COGT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · COGT · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
6
近12个月
买卖比
0.17
Buy/Sell (by trades)
整体情绪
Cogent Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
COGT 季度内部人买卖趋势
COGT 内幕交易卖出 · COGT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · COGT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
COGT 高管卖出股份 · COGT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 19, 2026 | Robbins Andrew R President and CEO · Director | Gift | 160,000 | — | Form 4 |
| May 19, 2026 | Robbins Andrew R President and CEO · Director | Gift | 160,000 | — | Form 4 |
| Mar 31, 2026 | Fairmount Funds Management LLC Director | Other | 7,000,000 | — | Form 4 |
| Mar 31, 2026 | Fairmount Funds Management LLC Director | Sale | 7,000,000 | $242.62M⚡ | Form 4 |
| Jan 22, 2026 | Fairmount Funds Management LLC Director | Sale | 3,500,000 | $127.40M⚡ | Form 4 |
| Dec 26, 2025 | Kearns Evan Chief Legal Officer | Sale | 65,000 | $2.52M⚡ | Form 4 |
| Dec 26, 2025 | Green John L. CFO | Sale | 77,000 | $2.98M⚡ | Form 4 |
| Dec 26, 2025 | Sachs Jessica Chief Medical Officer | Sale | 82,642 | $3.20M⚡ | Form 4 |
| Dec 26, 2025 | Robinson John Edward Chief Scientific Officer | Sale | 90,000 | $3.49M⚡ | Form 4 |
| Dec 17, 2025 | Robinson John Edward Chief Scientific Officer | Award | 320,000 | — | Form 4 |
| Dec 17, 2025 | Robinson John Edward Chief Scientific Officer | Other | 139,998 | $5.52M⚡ | Form 4 |
| Dec 17, 2025 | Robinson John Edward Chief Scientific Officer | Award | 50,000 | — | Form 4 |
| Dec 17, 2025 | Robbins Andrew R President and CEO · Director | Award | 840,000 | — | Form 4 |
| Dec 17, 2025 | Robbins Andrew R President and CEO · Director | Other | 367,497 | $14.50M⚡ | Form 4 |
| Dec 17, 2025 | Robbins Andrew R President and CEO · Director | Award | 185,000 | — | Form 4 |
| Dec 17, 2025 | Pinnow Cole Chief Commercial Officer | Award | 214,000 | — | Form 4 |
| Dec 17, 2025 | Pinnow Cole Chief Commercial Officer | Other | 94,800 | $3.74M⚡ | Form 4 |
| Dec 17, 2025 | Pinnow Cole Chief Commercial Officer | Award | 50,000 | — | Form 4 |
| Dec 17, 2025 | Kearns Evan Chief Legal Officer | Award | 260,000 | — | Form 4 |
| Dec 17, 2025 | Kearns Evan Chief Legal Officer | Other | 125,602 | $4.95M⚡ | Form 4 |
| Dec 17, 2025 | Kearns Evan Chief Legal Officer | Award | 40,000 | — | Form 4 |
| Dec 17, 2025 | Sachs Jessica Chief Medical Officer | Award | 320,000 | — | Form 4 |
| Dec 17, 2025 | Sachs Jessica Chief Medical Officer | Other | 154,716 | $6.10M⚡ | Form 4 |
| Dec 17, 2025 | Sachs Jessica Chief Medical Officer | Award | 50,000 | — | Form 4 |
| Dec 17, 2025 | Green John L. CFO | Award | 300,000 | — | Form 4 |
Fairmount Funds Management LLC
Director
日期
Mar 31
股数
7,000,000
均价
$34.66
总金额
$242.62M ⚡
Fairmount Funds Management LLC
Director
日期
Jan 22
股数
3,500,000
均价
$36.40
总金额
$127.40M ⚡
Robinson John Edward
Chief Scientific Officer
日期
Dec 26
股数
90,000
均价
$38.74
总金额
$3.49M ⚡
Robinson John Edward
Chief Scientific Officer
日期
Dec 17
股数
139,998
均价
$39.45
总金额
$5.52M ⚡
Robbins Andrew R
President and CEO · Director
日期
Dec 17
股数
367,497
均价
$39.45
总金额
$14.50M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 COGT 内幕交易
COGT 内幕交易
Cogent Biosciences, Inc.（COGT）内幕交易数据来源于公司内部人（包括Robbins Andrew R (President and CEO · Director), Fairmount Funds Management LLC (Director), Kearns Evan (Chief Legal Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。COGT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cogent Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
COGT 内幕交易 · 5个问题Cogent Biosciences, Inc.（COGT）的内部人包括高管和董事，如Robbins Andrew R (President and CEO · Director), Fairmount Funds Management LLC (Director), Kearns Evan (Chief Legal Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026